AACR Podcast: Michael B. Kastan, M.D., Ph.D.
Interview with Michael B. Kastan, M.D., Ph.D., director, Comprehensive Cancer Center, St. Jude Children's Research Hospital
Dr. Kastan talks about the roles of the ATM and p53 tumor suppressors in DNA damage responses and in the development of new therapies. As editor-in-chief of AACR's Molecular Cancer Research, he also discusses current research and trends in that field.
|NeonCRM by Neon One|